Drugs / Adjuvanted vaccine against H1N1 influenza virus
Adjuvanted vaccine against H1N1 influenza virus
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01155037 Comparator | Mar 2010 → Mar 2012 | HIV infectious disease | Oswaldo Cruz Foundation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Adjuvanted vaccine against H1N1 influenza virus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01155037 ↗ |
| Modality | Vaccine | “3.75 µg of an adjuvanted A H1N1 vaccine in two applications 21 days apart” NCT01155037 ↗ |